Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Global Artificial Pancreas Devices System Market 2016-2020

By: Technavio
, Published: Dec-2016
, Product code: IRTNTR11134
Key Insights

Companies mentioned in this product:

Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, Roche, Beta Bionics, Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda Diabetic, Type Zero Technologies.
Table of Contents
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• A glance at parent market: Artificial organs
PART 05: An overview of pancreas and diabetes
• Pancreas
• Diabetes
• Insulin overview
PART 06: Need for better systems in the management of diabetes
PART 07: Artificial pancreas device system
• Technology landscape
PART 08: Initiatives for the development of APDS
• Juvenile Diabetes Research Foundation (JDRF) initiative — 2006
• European Commission’s AP@home project — 2010
• Centre for bio-inspired technology — Bionic pancreas
• Harvard University — 2014
PART 09: FDA’s role in fostering the development of APDS
• Rapid response to preliminary study plans
• Interactive review of investigational device exemption study plans
• Guidance and standards for researchers and industry
PART 10: Reimbursement scenario
• Australia
• Germany
• UK
• US
PART 11: Key clinical trials
PART 12: Market landscape
• Market overview
• Five forces analysis
PART 13: Market segmentation by categories
• TSDS
• NTSDS
• CTRS
• CTTS
PART 14: Geographical segmentation
• APDS market in Americas
• APDS market in EMEA
• APDS market in APAC
PART 15: Market drivers
• Growing technological integration fuelling the market growth
• Increasing initiatives of research organizations fostering innovation in the market
• Increasing prevalence of diabetes fuelling the need for effective devices
PART 16: Impact of drivers
PART 17: Market challenges
• Lack of smart control algorithms affecting the adoption rate of existing APDS
• Low penetration rates affecting the market growth
• Lab-grown pancreatic cell transplant as a potential treatment alternative hindering the growth prospects
PART 18: Impact of drivers and challenges
PART 19: Market trends
• Increasing focus on closed loop systems
• Growing demand for remote monitoring applications
• Focus of new entrants on the development of novel APDS
PART 20: Vendor landscape
• Competitive scenario
PART 21: Key vendor analysis
• Medtronic
• Johnson & Johnson
• Insulet
• Tandem Diabetes Care
• Roche
• Other prominent vendors
PART 22: Appendix
• List of abbreviations
PART 23: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Key segments in artificial organ market
Exhibit 03: Diagnosis of diabetes by blood sugar test
Exhibit 04: Diagnosis of diabetes by glycated hemoglobin test
Exhibit 05: Treatment algorithm for type 2 diabetes
Exhibit 06: Factors that fuelled the need for APDS
Exhibit 07: Technology involved in the functioning of APDS
Exhibit 08: Barriers in CGM
Exhibit 09: Barriers in hormonal pumps
Exhibit 10: Key findings of researchers related to algorithms till date
Exhibit 11: Key clinical trials
Exhibit 12: Global APDS market snapshot
Exhibit 13: Development path of APDS
Exhibit 14: Global APDS market 2015-2020 ($ millions)
Exhibit 15: Key factors driving the demand for closed loop systems
Exhibit 16: Scenario analysis of global APDS market
Exhibit 17: Five forces analysis
Exhibit 18: Pipeline products
Exhibit 19: Key pipeline products
Exhibit 20: Scenario analysis of key segments in global APDS market
Exhibit 21: Segmentation of global APDS market based on geography 2015 and 2020
Exhibit 22: APDS market revenue by geography 2015-2020 ($ millions)
Exhibit 23: Market scenario in Americas
Exhibit 24: APDS market in the Americas ($ millions)
Exhibit 25: Market scenario in EMEA
Exhibit 26: APDS market in EMEA ($ millions)
Exhibit 27: Market scenario in EMEA
Exhibit 28: APDS market in APAC ($ millions)
Exhibit 29: Key technological integrations
Exhibit 30: Key initiatives of research organizations
Exhibit 31: Incidence and prevalence for diabetes in the US
Exhibit 32: Traditional systems vs APDS
Exhibit 33: Impact of drivers
Exhibit 34: Forcefield analysis of drivers and challenges
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Key trends in the development of closed loop systems
Exhibit 37: Key products under development for remote monitoring applications
Exhibit 38: New entrants and their expected product launches
Exhibit 39: Competitive structure analysis of global APDS market 2015
Exhibit 40: Competitive analysis of global APDS market
Exhibit 41: Market share analysis 2015
Exhibit 42: Market penetration of various APDS manufacturers in global (2015)
Exhibit 43: Timeline chart representing the development of APDS
Exhibit 44: Strategic success factors of companies in global APDS market
Exhibit 45: Key highlights
Exhibit 46: Strength assessment
Exhibit 47: Strategy assessment
Exhibit 48: Opportunity assessment
Exhibit 49: Key highlights
Exhibit 50: Strength assessment
Exhibit 51: Strategy assessment
Exhibit 52: Opportunity assessment
Exhibit 53: Key highlights
Exhibit 54: Strength assessment
Exhibit 55: Strategy assessment
Exhibit 56: Opportunity assessment
Exhibit 57: Key highlights
Exhibit 58: Strength assessment
Exhibit 59: Strategy assessment
Exhibit 60: Opportunity assessment
Exhibit 61: Key highlights
Exhibit 62: Strength assessment
Exhibit 63: Strategy assessment
Exhibit 64: Opportunity assessment
Sample Pages

Request Sample Pages

Global Artificial Pancreas Devices System Market 2016-2020
By: Technavio